Custro N, Scafidi V, Costanzo G, Notarbartolo A
Cattedra di Patologia Medica, Istituto di Medicina Interna e Geriatria, Università degli Studi di Palermo.
Ann Ital Med Int. 1992 Jan-Mar;7(1):13-8.
Patients with severe non-thyroidal illness (NTI) often evidence concomitant anomalies in thyroid function (TF). In order to shed light on the implications of these anomalies and/or changes and disease course, we monitored TF changes in a selected cohort of 45 patients with serious NTI (21 with liver cirrhosis, 15 with renal failure and 9 with malignancy) from April 1985 to October 1989. TF test results on admission were as follows: all patients had normal thyroid stimulating hormone (TSH) levels; 16 patients had no TF abnormalities; 28 had decreased serum triiodothyronine (T3) and increased serum reverse triiodothyronine (rT3) levels, (8 of them had low serum free T3 values as well); 1 patient had subnormal level of both T3 and thyroxine (T4). Fifteen (53.5%) of the 28 subjects with initial low T3 sustained a subsequent decline in total and free serum T4 to subnormal levels; in 13 of these patients the drop occurred shortly before death. Patients in critical condition with below normal serum T4 also had decreased serum TSH concentrations: the so-called "low T3 and low T4 syndrome" might thus result from decreased TSH concentrations: due to failure of the usual feedback mechanism. Eighteen patients (40%) had died by the end of the study period. The mortality rate was 89% in patients with initial T3 level less than 0.40 nmol/L. This finding leads us to the hypothesis that initial low T3 levels in NTI patients are indicative of a poor prognosis.
患有严重非甲状腺疾病(NTI)的患者常常伴有甲状腺功能(TF)异常。为了阐明这些异常和/或变化及其对疾病进程的影响,我们对1985年4月至1989年10月期间选定的45例患有严重NTI的患者(21例肝硬化患者、15例肾衰竭患者和9例恶性肿瘤患者)的TF变化进行了监测。入院时的TF检测结果如下:所有患者的促甲状腺激素(TSH)水平均正常;16例患者无TF异常;28例患者血清三碘甲状腺原氨酸(T3)降低,血清反三碘甲状腺原氨酸(rT3)升高(其中8例患者血清游离T3值也较低);1例患者的T3和甲状腺素(T4)水平均低于正常。28例初始T3水平低的患者中有15例(53.5%)随后血清总T4和游离T4降至低于正常水平;其中13例患者在死亡前不久出现下降。血清T4低于正常的危重症患者血清TSH浓度也降低:因此,所谓的“低T3和低T4综合征”可能是由于通常的反馈机制失效导致TSH浓度降低所致。到研究结束时,18例患者(40%)已经死亡。初始T3水平低于0.40 nmol/L的患者死亡率为89%。这一发现使我们提出一个假设,即NTI患者初始低T3水平预示预后不良。